CompletedNot applicableNCT01711983
Safety and Efficacy of the GORE® Septal Occluder to Treat Ostium Secundum Atrial Septal Defects
Studying Interatrial communication
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- W.L.Gore & Associates
- Principal Investigator
- D. Scott Lim, MDUniversity of Virginia, Children's Hospital Heart Center
- Intervention
- GORE® CARDIOFORM Septal Occluder(device)
- Enrollment
- 400 target
- Eligibility
- All sexes
- Timeline
- 2012 – 2018
Study locations (1)
- University of Virginia, Children's Hospital Heart Center, Charlottesville, Virginia, United States
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT01711983 on ClinicalTrials.govOther trials for Interatrial communication
Additional recruiting or active studies for the same condition.
- RECRUITINGNCT06849635Cera™ ASD Occluder Post-Market Clinical Follow-Up StudyLifetech Scientific (Shenzhen) Co., Ltd.
- RECRUITINGNCT06700174Lifetech AcuMark™ Sizing Balloon Post-Market Clinical Follow-up StudyLifetech Scientific (Shenzhen) Co., Ltd.
- RECRUITINGNCT06590467Abbott Structural Heart Device RegistryAbbott Medical Devices
- RECRUITINGNCT05887700Lifetech CeraFlex™ ASD Closure System Post-Market Clinical Follow-UpLifetech Scientific (Shenzhen) Co., Ltd.
- RECRUITINGPHASE4NCT06631534Effect of Dexmedetomidine Supplementation to General Anaesthesia in Paediatric Transcatheter Closure of Atrial Septal DefectAlexandria University
- RECRUITINGNCT06347276Cerebral Microembolization Associated With PFO ClosureChina National Center for Cardiovascular Diseases
- RECRUITINGNANCT02097758Efficacy of Three Dimensional Transesophageal Echocardiography for Percutaneous Device Closure in Atrial Septal DefectAsan Medical Center